Abstract:Background. Clear cell renal cell carcinoma (ccRCC) accounts for more than 80% of renal cell carcinomas. Yet, it has not been fully understood about the derivation and progression of the tumor, as well as the long-term benefits from multimodality therapy. Therefore, reliable and applicable molecular markers are urgently needed for the prediction of diagnosis and prognosis of ccRCC patients. Methods. Genetic and clinical information of 533 ccRCC patients from The Cancer Genome Atlas database was collected for comprehensive bioinformatic analyses. UALCAN was used to detect gene expression in paired tumor samples. Two data sets from Gene Expression Omnibus database were analyzed to identify differentially expressed genes (DEGs), and Gene Set Enrichment Analysis was applied for the functional enrichment of DEGs. Tumor Immune Single Cell Hub and Tumor IMmune Estimation Resource databases were separately used for analyses of single-immune cell and immune cell infiltration. Encyclopedia of RNA Interactomes database was explored to predict targeted microRNAs (miRNAs) and corresponding long non-coding RNAs (lncRNAs). Cox regression analysis was performed for the construction of risk signature and prognosis model. Finally, quantitative real-time polymerase chain reaction and western blot were conducted for KCNN4 expression detection in cell lines and clinical samples. Small interfering RNA was employed to knock down KCNN4, and corresponding functional experiments were conducted on ccRCC cells as well. Results. KCNN4 showed elevated expression in tumors and prominent clinical correlation in ccRCC. In total, 41 KCNN4-related genes were enriched, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses showed they were intimately related to immune-related signaling pathways. Spearman’s analysis revealed the significantly positive correlation of KCNN4 with immune cell infiltration. By integrating hub miRNA-let-7e-5p and four critical lncRNA, a competitive endogenous RNA network-based risk signature was constructed. The prognosis model derived from it showed considerable predictive value for survival of ccRCC patients. Finally, in vitro experiments confirmed the remarkable tumor-promoting role of KCNN4 in ccRCC cells. Conclusion. KCNN4 significantly affected the immune status of tumor microenvironment and immunotherapy elements, through which it promoted tumor progression in ccRCC, and it could be a potential biomarker for prognosis and immunotherapy effects of ccRCC patients.

Screening of the interaction protein with Wnt signaling molecular-TCF4 from renal carcinoma cDNA library by yeast two hybrid

Wnt/Frizzled Signaling Pathway in Renal Carcinoma

Screening for Proteins Interacting with Novel Gene Collectrin in Adult Human Kidney Cdna Library by Yeast Two Hybrid System

Interaction of Htcf4 by Yeast Two-Hybrid System

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma

Aberrant Activity of Wnt/Frizzled Signaling Pathway in Renal Cancer Cell Lines

Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells.

Functional Interaction of TCF4 with ATF5 to Regulate the Wnt Signaling Pathway

Identification of Candidate Genes Related to Renal Carcinoma using Protein Interactions and Structures

Yeast two-hybrid assay for screening proteins interacting with HCV NS4B in human leukocytes cDNA library

Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin Β4 and Vascular Endothelial Growth Factor As Downstream Targets

Development of a Novel Fluorescence Polarization–Based Assay for Studying the Β-Catenin/tcf4 Interaction

Netrin Family Genes as Prognostic Markers and Therapeutic Targets for Clear Cell Renal Cell Carcinoma: Netrin-4 Acts through the Wnt/β-Catenin Signaling Pathway

[Screening for Proteins Interacting with Novel Gene AngRem104 in the Adult Human Kidney Cdna Library by Yeast Two Hybrid System].

Screening of renal clear cell carcinoma prognostic marker genes based on TCGA and GTEx chip data and construction of transcription factor-related regulatory networks

HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.

Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database

Screening of the genes of HCV core interacting proteins from human leucocyte cDNA library by yeast two-hybrid system

Development of a Novel KCNN4-Related Cerna Network and Prognostic Model for Renal Clear Cell Carcinoma

Screening of Proteins Interacting with Gankyrin by Yeast Two-Hybrid in Human Breast cDNA Library

Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.